Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of temozolomide for the treatment of mycosis fungoides and the Sezary syndrome.

Trial Profile

Phase II trial of temozolomide for the treatment of mycosis fungoides and the Sezary syndrome.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2012

At a glance

  • Drugs Temozolomide (Primary)
  • Indications Mycosis fungoides; Sezary syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 13 Jul 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 28 Jan 2011 Planned end date added 1 Jul 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top